Latest News About Cecile Tremblay

Updated 2026-04-17 20:04

I can help with current updates, but I don’t have live access to news streams right now. Based on available public information, here’s what’s known about a person named Cécile Tremblay in the HIV/immunology field up to recent years, which may or may not reflect the exact “Cecile Tremblay” you’re asking about if there are multiple individuals with that name.

Direct answer

Context and likely matches

What I can do next

Notes on citations

If you want, I can perform a focused, real-time search for the latest news on a specific Cecile Tremblay (e.g., with a middle initial, country, or institution) and summarize credible sources.

Sources

Cécile Tremblay

Cécile Tremblay is an infectious diseases/medical microbiologist specialist and the Université de Montréal/Pfizer Chair on Translational HIV Research. She is full professor in the Department of Microbiology, Immunology, and Infectious Diseases at University of Montreal and a researcher at Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CHUM). She obtained her M.D. at University of Montreal in 1992. She did her residency in medical microbiology and infectious diseases at...

www.aginghiv.com

Cécile Tremblay - CIRN

Cécile Tremblay is a Full Professor, Department of Microbiology, Infectious Diseases and Immunology at the Université de Montréal, Microbiologist infectious diseases specialist, CHUM, Director of Research at UHRESS, CHUM, Scientific Director, Laboratoire de Santé Publique du Québec. Her research interests include: Viral evolution under immunotherapeutic pressure, pre-clinical evaluation of antiretrovirals, entry inhibitors, resistance to antiretrovirals. Email: [email protected]

cirnetwork.ca

Dr. Cécile Tremblay (Professor, Department of Microbiology, Infectiology and Immunology, Faculty of Medicine, Université de Montréal, As an Individual) at the Health Committee

Today, I'm talking to you as a researcher, a clinician and a public health scientist. Let's talk research. First, I want to congratulate the Canadian government on its rapid response to the pandemic with the investment of specific funds directed at COVID-19 research very early on in February, and then again in the month of May. There was an urgent need to support research teams already in place in order to advance innovation, mostly in treatment and vaccine development, to counter this...

openparliament.ca